Immunohistological study of temporal arteritis. Influence of corticosteroid treatment;Etude immunohistochimique des lesions d'arterite temporale de Horton avant et au cours de la corticotherapie

Revue de Medecine Interne

Volumn 17, Issue 10, 1996, Pages 814-820

  Lavignac, C ^a   Jauberteau Marchan, M O ^a   Liozon, E ^a   Vidai, E ^a   Catanzano, G ^a   Liozon, F ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

adhesion molecules; corticoid treatment; giant cell (temporal) arteritis; immunohistochemistry

Indexed keywords

CORTICOSTEROID; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE; PREDNISOLONE; CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NATURAL KILLER CELL; PATHOGENESIS; T LYMPHOCYTE; TEMPORAL ARTERITIS; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE; TEMPORAL ARTERY;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; BIOPSY; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; RECURRENCE; T-LYMPHOCYTES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 0030271619     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/0248-8663(96)82684-1     Document Type: Article

References (27)

1. Liozon F, Catanzano G. L'artérite temporale de Horton. Étude anatomopathologique en microscopie optique. À propos de 123 biopsies temporales. Rev Méd Interne 1982;3:295-301
2. Andersson R, Jonsson R, Tarkowski A, Bengtsson BA, Malmvall BE. T-cell subsets and expression of immunological activation markers in the arterial wall of patients with giant cell arteritis. Ann Rheum Dis 1987;46:915-23
3. Andersson R, Hanson GK, Soderström T, Jonsson R, Bengtsson BA, Norborg E. HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis. Clin Exp Immunol 1988;73:82-7
4. Banks PM, Cohen MD, Ginsburg WW, Hunder GG. Immunohistologic and cyto-chemical study of temporal arteritis. Arthritis Rheum 1983;26:1201-7
5. Chess J, Albert DM, Bhan AK et al. Serologic and immunopathologic findings in temporal arteritis. Am J Ophtalmol 1983;96:283-9
6. Cid MC, Campo E, Ercilla G et al. Immunohistochemical analysis of lymphoid and macrophage cell subset and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum 1989;32:884-93
7. Gallagher P, Jones K. Immunohistochemical findings in cranial arteritis. Arthritis Rheum 1982;25:75-9
8. Liozon F, Lavignac C, Emilie D et al. Étude en immunohistochimie des lésions d'artérite temporale de la maladie de Horton. Ann Méd Interne 1993;144:85-91
9. Park JR, Hazleman BL, Immunological and histological study of temporal arteries. Ann Rheum Dis 1976;37:238-43
10. Bierer BE, Hahn WC. T cell adhesion, avidity, regulation and signaling: a molecular analysis of CD2. Semin Immunol 1993;5:249-61
11. Van Der Merwe PA, Barclay AN, Mason DW et al. Human celladhesion molecules CD2 binds CD58 (LFA3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD 59. Biochemistry 1994;33:10149-60
12. Dubey C, Croft M, Swain SL. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4+ cell activation but both are required for optimum response. J Immunol 1995;155:45-57
13. Yamada A, Keneyuki T, Torimoto Y, Daley JF, Prado CM, Yokoyama MM. Signaling from LFA1 contributes signal transduction through CD2 alternative pathway in T cell activation. Cell Immunol 1992;142:145-58
14. Chong AS, Boussy IA, Jiang XL, Lamas M, Graf LH Jr. CD 54: ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol 1994;157:92-105
15. Somersalo K, Tarkkaanen J, Patarroyo M, Saksela E. Involve-ment of beta 2-integrins in the migration of human natural killer cells. J Immunol 1992;149:590-8
16. Cartwright JE, Whitley GS, Johnstone AP. The expression and release of adhesion molecules by human endothelial cell lines and their consequent binding of lymphocytes. Exp Cell Res 1995;217:329-35
17. Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD 11 A/CD 18, CD11b/CD18 and VLA4 on monocytes and ICAM-1, VCAM-1 and other ligands on endothelium. J Immunol 1995;154:4O99-112
18. Cornwell RD, Gollahon KA, Hickstein DD. Description of the leukocyte function-associated antigen 1 (LFA-1 or CD11a) promoter. Proc Nail Acad Sci USA 1993;90:4221-5
19. Pham-Huu T. Molécules d'adhésion des leucocytes Leu CAMs. Presse Méd 1993:22:1357-62
20. Shiiki H, Shimokama T, Watanabe T. Temporal arteritis: cell composition and the possible pathogenic role of cell-mediated immunity. Hum Pathol 1989;20:1057-64
21. Wawryk SO, Ayberk H, Boyd AW, Rode J. Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis. J Clin Pathol 1991;44:497-501
22. Frieto J, Eklund A, Patarroyo M. Regulated expression of integrins and other adhesion molecules during differenciation of monocytes in macrophages. Cell Immuol 1994;156:191-211
23. Stemme S, Patarroyo M, Hansson GK. Adhesion of activated T lymphocytes to vascular smooth muscle cells and dermal fibroblasts is mediated by betal- and beta2- integrins. Scand J Immunol 1992;36:233-42
24. Emilie D, Liozon E, Crevon MC et al. Production of interleukin 6 by granulomas of giant cell arteritis. Hum Immunol 1994;39:17-24
25. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-91
26. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy finding in giant cell (temporal) arteritis. Ann Intern Med 1994;120 (12):987-92
27. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, WEyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993;9:1286-94